BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• FDA

  FDA Approves New Dosage Strengths For Novartis Corporation’s Lotrel(R)

  June 9, 2006

   · 

  6 min read
• Drug Development

  Acologix, Inc. Presents Preclinical Data On Bone Formation And Maturation Stimulated By AC-100 At The European Orthopedic Research Society Meeting

  June 9, 2006

   · 

  1 min read
• Genetown

  NxStage Medical, Inc. Announces Pricing Of Follow-On Offering Of 5,613,371 Shares Of Common Stock

  June 9, 2006

   · 

  1 min read
• Business

  Isolagen, Inc. Appoints Chief Financial Officer And Senior VP

  June 9, 2006

   · 

  1 min read
• Nymox Pharmaceutical Holds Annual Shareholders Meeting

  June 9, 2006

   · 

  1 min read
• Business

  Neoprobe Corporation Announces Results Of Annual Meeting

  June 9, 2006

   · 

  1 min read
• Sanofi-Aventis (France) Suspends Ketek Clinical Trial Enrollment

  June 9, 2006

   · 

  1 min read
• Policy

  BioDelivery Sciences International Announces Promising Results Of Meeting With FDA On Emezine(R)

  June 9, 2006

   · 

  8 min read
• Drug Development

  Nymox Pharmaceutical Reports Completion Of NX-1207 Dosing In Current Multi-Center BPH Drug Trial

  June 9, 2006

   · 

  1 min read
• FDA

  FDA Approves New Indication For ZETIA(R), Merck & Co., Inc. And Schering-Plough Corporation’s Cholesterol Lowering Drug

  June 9, 2006

   · 

  7 min read